Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing

Maneesh Ailawadi, Jay M. Lee, Sang Lee, Neil Hackett, Ronald Crystal, Robert J. Korst

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background. We hypothesized that adenovirus-mediated transfer of the vascular endothelial growth factor (VEGF121) complementary DNA (cDNA) to murine laparotomy fascial wounds would enhance vascularity and bursting strength. Methods. Microfibrillar collagen sponges saturated with adenovirus (Ad) vectors encoding for the human VEGF121 cDNA (AdCUVEGF121.1), a control marker gene (Adβgal, AdLuc) or no transgene (AdNull) were sutured to fascial edges during laparotomy closure in normal mice and mice treated with dexamethasone. Endpoints addressed included transgene expression in the fascia and surrounding tissue, the number of blood vessels in the healing wound determined using immunostaining, and wound bursting strength using a calibrated tensinometer. Results. Transgene expression was detected readily in the fascial edges, but only marginally detectable in neighboring tissues. In normal mice and mice treated with dexamethasone, no differences were observed at 7 days. Strikingly, however, 21 days after wound closure/therapy, significantly more blood vessels were present in the wounds that received the VEGF121 vector compared with controls (normal: AdNull: 4.2 ± 1.8; AdCUVEGF121.1: 11.2 ± 1.2; P < .05; dexamethasone: AdNull: 1.4 ± 0.8; AdCUVEGF121.1: 5.4 ± 1.2; P < .05), and bursting strength was significantly higher in VEGF121-treated wounds (normal: AdNull: 665 ± 68 mN/mm; AdCUVEGF121.1: 956 ± 82 mN/mm; P < .0005; dexamethasone: AdNull: 234 ± 111 mN/mm; AdCUVEGF121.1: 592 ± 121 mN/mm; P < .03). Conclusions. Adenovirus-mediated gene transfer to healing fascial wounds is achieved readily using a microfibrillar collagen sponge, with transfer of the human VEGF121 cDNA significantly enhancing wound vascularity and bursting strength in normal mice, as well as in mice treated with dexamethasone.

Original languageEnglish
Pages (from-to)219-227
Number of pages9
JournalSurgery
Volume131
Issue number2
DOIs
Publication statusPublished - 1 Jan 2002
Externally publishedYes

Fingerprint

Fascia
Adenoviridae
Wound Healing
Vascular Endothelial Growth Factor A
Complementary DNA
Dexamethasone
Wounds and Injuries
Transgenes
Porifera
Laparotomy
Blood Vessels
Collagen
Genes

ASJC Scopus subject areas

  • Surgery

Cite this

Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing. / Ailawadi, Maneesh; Lee, Jay M.; Lee, Sang; Hackett, Neil; Crystal, Ronald; Korst, Robert J.

In: Surgery, Vol. 131, No. 2, 01.01.2002, p. 219-227.

Research output: Contribution to journalArticle

@article{bcf28f05e8464eb5be8ba7e33295343e,
title = "Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing",
abstract = "Background. We hypothesized that adenovirus-mediated transfer of the vascular endothelial growth factor (VEGF121) complementary DNA (cDNA) to murine laparotomy fascial wounds would enhance vascularity and bursting strength. Methods. Microfibrillar collagen sponges saturated with adenovirus (Ad) vectors encoding for the human VEGF121 cDNA (AdCUVEGF121.1), a control marker gene (Adβgal, AdLuc) or no transgene (AdNull) were sutured to fascial edges during laparotomy closure in normal mice and mice treated with dexamethasone. Endpoints addressed included transgene expression in the fascia and surrounding tissue, the number of blood vessels in the healing wound determined using immunostaining, and wound bursting strength using a calibrated tensinometer. Results. Transgene expression was detected readily in the fascial edges, but only marginally detectable in neighboring tissues. In normal mice and mice treated with dexamethasone, no differences were observed at 7 days. Strikingly, however, 21 days after wound closure/therapy, significantly more blood vessels were present in the wounds that received the VEGF121 vector compared with controls (normal: AdNull: 4.2 ± 1.8; AdCUVEGF121.1: 11.2 ± 1.2; P < .05; dexamethasone: AdNull: 1.4 ± 0.8; AdCUVEGF121.1: 5.4 ± 1.2; P < .05), and bursting strength was significantly higher in VEGF121-treated wounds (normal: AdNull: 665 ± 68 mN/mm; AdCUVEGF121.1: 956 ± 82 mN/mm; P < .0005; dexamethasone: AdNull: 234 ± 111 mN/mm; AdCUVEGF121.1: 592 ± 121 mN/mm; P < .03). Conclusions. Adenovirus-mediated gene transfer to healing fascial wounds is achieved readily using a microfibrillar collagen sponge, with transfer of the human VEGF121 cDNA significantly enhancing wound vascularity and bursting strength in normal mice, as well as in mice treated with dexamethasone.",
author = "Maneesh Ailawadi and Lee, {Jay M.} and Sang Lee and Neil Hackett and Ronald Crystal and Korst, {Robert J.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1067/msy.2002.118709",
language = "English",
volume = "131",
pages = "219--227",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing

AU - Ailawadi, Maneesh

AU - Lee, Jay M.

AU - Lee, Sang

AU - Hackett, Neil

AU - Crystal, Ronald

AU - Korst, Robert J.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Background. We hypothesized that adenovirus-mediated transfer of the vascular endothelial growth factor (VEGF121) complementary DNA (cDNA) to murine laparotomy fascial wounds would enhance vascularity and bursting strength. Methods. Microfibrillar collagen sponges saturated with adenovirus (Ad) vectors encoding for the human VEGF121 cDNA (AdCUVEGF121.1), a control marker gene (Adβgal, AdLuc) or no transgene (AdNull) were sutured to fascial edges during laparotomy closure in normal mice and mice treated with dexamethasone. Endpoints addressed included transgene expression in the fascia and surrounding tissue, the number of blood vessels in the healing wound determined using immunostaining, and wound bursting strength using a calibrated tensinometer. Results. Transgene expression was detected readily in the fascial edges, but only marginally detectable in neighboring tissues. In normal mice and mice treated with dexamethasone, no differences were observed at 7 days. Strikingly, however, 21 days after wound closure/therapy, significantly more blood vessels were present in the wounds that received the VEGF121 vector compared with controls (normal: AdNull: 4.2 ± 1.8; AdCUVEGF121.1: 11.2 ± 1.2; P < .05; dexamethasone: AdNull: 1.4 ± 0.8; AdCUVEGF121.1: 5.4 ± 1.2; P < .05), and bursting strength was significantly higher in VEGF121-treated wounds (normal: AdNull: 665 ± 68 mN/mm; AdCUVEGF121.1: 956 ± 82 mN/mm; P < .0005; dexamethasone: AdNull: 234 ± 111 mN/mm; AdCUVEGF121.1: 592 ± 121 mN/mm; P < .03). Conclusions. Adenovirus-mediated gene transfer to healing fascial wounds is achieved readily using a microfibrillar collagen sponge, with transfer of the human VEGF121 cDNA significantly enhancing wound vascularity and bursting strength in normal mice, as well as in mice treated with dexamethasone.

AB - Background. We hypothesized that adenovirus-mediated transfer of the vascular endothelial growth factor (VEGF121) complementary DNA (cDNA) to murine laparotomy fascial wounds would enhance vascularity and bursting strength. Methods. Microfibrillar collagen sponges saturated with adenovirus (Ad) vectors encoding for the human VEGF121 cDNA (AdCUVEGF121.1), a control marker gene (Adβgal, AdLuc) or no transgene (AdNull) were sutured to fascial edges during laparotomy closure in normal mice and mice treated with dexamethasone. Endpoints addressed included transgene expression in the fascia and surrounding tissue, the number of blood vessels in the healing wound determined using immunostaining, and wound bursting strength using a calibrated tensinometer. Results. Transgene expression was detected readily in the fascial edges, but only marginally detectable in neighboring tissues. In normal mice and mice treated with dexamethasone, no differences were observed at 7 days. Strikingly, however, 21 days after wound closure/therapy, significantly more blood vessels were present in the wounds that received the VEGF121 vector compared with controls (normal: AdNull: 4.2 ± 1.8; AdCUVEGF121.1: 11.2 ± 1.2; P < .05; dexamethasone: AdNull: 1.4 ± 0.8; AdCUVEGF121.1: 5.4 ± 1.2; P < .05), and bursting strength was significantly higher in VEGF121-treated wounds (normal: AdNull: 665 ± 68 mN/mm; AdCUVEGF121.1: 956 ± 82 mN/mm; P < .0005; dexamethasone: AdNull: 234 ± 111 mN/mm; AdCUVEGF121.1: 592 ± 121 mN/mm; P < .03). Conclusions. Adenovirus-mediated gene transfer to healing fascial wounds is achieved readily using a microfibrillar collagen sponge, with transfer of the human VEGF121 cDNA significantly enhancing wound vascularity and bursting strength in normal mice, as well as in mice treated with dexamethasone.

UR - http://www.scopus.com/inward/record.url?scp=0036183667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036183667&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.118709

DO - 10.1067/msy.2002.118709

M3 - Article

VL - 131

SP - 219

EP - 227

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 2

ER -